Paper39196380
Recent advances in CD5+ diffuse large B-cell lymphoma.
Yue N and 5 others. Ann Hematol, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Recent advances in CD5+ diffuse large B-cell lymphoma. Papers, record 39196380. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39196380
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | Major topic |
| CD5 Antigens | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Doxorubicin | Major topic |
| Humans | |
| Cyclophosphamide | |
| Rituximab | |
| Vincristine | |
| Prednisone | |
| Female | |
| Etoposide | |
| Male | |
| Prognosis |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 8226010026 | National Natural Science Foundation of China | PubMed | ||
| 22JR11RA053 | Scientific Research Project of Gansu Province | PubMed | ||
| 201710 | The "CuiYing postgraduate tutor" training program of Lanzhou University Second Hospital | PubMed |
Source PubMed
References89
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23375551 | Diffuse large B-cell lymphoma. | Crit Rev Oncol Hematol | 2013 | https://conductscience.org/library/papers/23375551 | PubMed |
| 2 | 35167823 | All roads lead to targeted diffuse large B-cell lymphoma approaches. | Cancer Cell | 2022 | https://conductscience.org/library/papers/35167823 | PubMed |
| 3 | 25499448 | Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. | Blood | 2015 | https://conductscience.org/library/papers/25499448 | PubMed |
| 4 | 18556402 | De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients. | Haematologica | 2008 | https://conductscience.org/library/papers/18556402 | PubMed |
| 5 | 11806981 | De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. | Blood | 2002 | https://conductscience.org/library/papers/11806981 | PubMed |
| 6 | 26369546 | CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma. | Virchows Arch | 2015 | https://conductscience.org/library/papers/26369546 | PubMed |
| 7 | 18573805 | CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy. | Ann Oncol | 2008 | https://conductscience.org/library/papers/18573805 | PubMed |
| 8 | 11061284 | Genomic organization of the human CD5 gene. | Immunogenetics | 2000 | https://conductscience.org/library/papers/11061284 | PubMed |
| 9 | 10379049 | CD5 expression in human B-cell populations. | Immunol Today | 1999 | https://conductscience.org/library/papers/10379049 | PubMed |
| 10 | 30581443 | CD5, an Undercover Regulator of TCR Signaling. | Front Immunol | 2018 | https://conductscience.org/library/papers/30581443 | PubMed |
| 11 | 3264319 | Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. | J Exp Med | 1988 | https://conductscience.org/library/papers/3264319 | PubMed |
| 12 | 25907284 | B cells generated by B-1 development can progress to chronic lymphocytic leukemia. | Ann N Y Acad Sci | 2015 | https://conductscience.org/library/papers/25907284 | PubMed |
| 13 | 2934473 | Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. | J Immunol | 1986 | https://conductscience.org/library/papers/2934473 | PubMed |
| 14 | 19228640 | Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome). | Am J Clin Pathol | 2009 | https://conductscience.org/library/papers/19228640 | PubMed |
| 15 | 32694049 | De Novo CD5+ Diffuse Large B-Cell Lymphoma: Biology, Mechanism, and Treatment Advances. | Clin Lymphoma Myeloma Leuk | 2020 | https://conductscience.org/library/papers/32694049 | PubMed |
| 16 | 11751967 | CD5-negative regulation of B cell receptor signaling pathways originates from tyrosine residue Y429 outside an immunoreceptor tyrosine-based inhibitory motif. | J Immunol | 2002 | https://conductscience.org/library/papers/11751967 | PubMed |
| 17 | 11043765 | Regulation of the phospholipase C-gamma2 pathway in B cells. | Immunol Rev | 2000 | https://conductscience.org/library/papers/11043765 | PubMed |
| 18 | 10327049 | Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1. | Oncogene | 1999 | https://conductscience.org/library/papers/10327049 | PubMed |
| 19 | 10903736 | Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells. | J Immunol | 2000 | https://conductscience.org/library/papers/10903736 | PubMed |
| 20 | 10082557 | CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. | Mol Cell Biol | 1999 | https://conductscience.org/library/papers/10082557 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42266738 | A study comparing the efficacy of R-CHOP and R-DA-EPOCH regimens in young, high-risk treatment-naïve diffuse large B-cell lymphoma patients: a multicenter retrospective analysis. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42266738 | PubMed |
| 41443849 | Efficacy and safety of Pola-R-mini-CHP therapy in patients aged ≥80 years with CD5-positive diffuse large B-Cell lymphoma. | J Clin Exp Hematop | 2026 | https://conductscience.org/library/papers/41443849 | PubMed |
| 41088985 | The EP300-Targeting Drug CCS1477 Inhibits the Growth and Development of Diffuse Large B-Cell Lymphoma by Promoting Apoptosis and Mitophagy to Reduce Drug Resistance. | Anticancer Agents Med Chem | 2026 | https://conductscience.org/library/papers/41088985 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| CD5 | 921 | PubTator's text mining | https://conductscience.org/library/genes/921 | NCBI Gene |
| CXCR4 | 7852 | PubTator's text mining | https://conductscience.org/library/genes/7852 | NCBI Gene |
| IBTK | 25998 | PubTator's text mining | https://conductscience.org/library/genes/25998 | NCBI Gene |
| MME | 4311 | PubTator's text mining | https://conductscience.org/library/genes/4311 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| PWWP3A | 84939 | PubTator's text mining | https://conductscience.org/library/genes/84939 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39196380
GET https://conductscience.org/api/papers/v1/39196380/references?page=2